ArticleInternational journal of emergency medicine2026
Ultrasonographic diaphragmatic assessment as an emergency mortality predictor in acute exacerbation of COPD.
Article in International journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the role of diaphragmatic ultrasound as a mortality predictor in acute exacerbation of chronic obstructive pulmonary disease (AECOPD), compared to the DECAF and BAP65 scoring systems.
backgroundThe diaphragm is the primary muscle of respiration and is often compromised during AECOPD. Bedside ultrasound offers a non-invasive method to assess diaphragmatic function. Early identification of patients at high risk of mortality upon presentation may aid in appropriate triage and management.
methodsThis observational pilot study included 50 patients presenting to the emergency department with AECOPD. For each patient, the BAP65 score (Blood urea nitrogen, altered mental status, Pulse, Age ≥ 65), DECAF score (Dyspnea, Eosinopenia, Consolidation, Acidemia, Atrial fibrillation), diaphragmatic thickness fraction (diTF), and diaphragmatic excursion (diEX) were recorded at presentation.
resultsOf the 63 patients initially enrolled, 50 completed the study, with a predominance of male participants. Mortality occurred in 16% of cases. Deceased patients were significantly more likely to have comorbidities such as diabetes mellitus, hypertension, atrial fibrillation, ischemic heart disease, cardiomyopathy, cerebrovascular stroke, chronic kidney disease, and reliance on home oxygen therapy (P < 0.05). Receiver operating characteristic (ROC) analysis identified cutoff values for each predictor: BAP65 ≥ 5, DECAF ≥ 3, diTF ≤ 21%, and diEX ≤ 2.5 cm. Corresponding area under the curve (AUC) values were: BAP65, 0.833, CI = 0.621 to 1.000; DECAF, 0.976, CI = 0.933 to 1.000; diTF, 0.848, CI = 0.670 to 1.026; and diEX, 0.884, CI = 0.787 to 0.981. Spearman’s rank correlation revealed a strong negative correlation between diEX and DECAF (r = -0.771, CI= -0.862–-0.628, p < 0.001), and between diEX and BAP65 (r = -0.626, CI = -0.757–-0.448, p < 0.001). Moderate negative correlation was also observed between diTF and DECAF (r = -0.451, CI = 0.616–-0.241, p < 0.001), and weak negative correlation between diTF and BAP65 (r = -0.341, CI =-0.570–-0.069, p = 0.01). However, these finding should be interpreted with caution due to small sample size.
conclusionDiaphragmatic ultrasound is a rapid and reliable tool for predicting mortality in patients with AECOPD presenting to the emergency department. It demonstrates comparable or superior predictive value to established scoring systems such as BAP65 and DECAF. However, this finding should be interpreted with caution and further studies with larger sample sizes are warranted to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.